-transparent.png){kind=logo}
The analysis of loss of heterozygosity (LOH) in tumours can be a powerful tool for mapping the sites of tumour suppressor genes in the human genome. A panel of breast cancer patients was assembled as pairs of tumour and lymphocyte DNA samples and LOH studies carried out by Southern hybridisation with polymorphic loci mapping to the X chromosome with appropriate controls. Deletion mapping revealed a high frequency of small regionalised deletions, defining at least three independent regions, one of which is particularly well mapped to a 500 kb stretch of DNA in the distal portion of the pseudoautosomal region of Xp. A second region has been identified within the pseudoautosomal region close to the pseudoautosomal boundary, and there is a third discrete site of loss on distal Xq. Perturbations of sequences at these regions represent independent events in a number of patients. This study represents the first detailed analysis of LOH on the X chromosome in human breast tumours, the results of which indicate that at least three regions of this chromosome are involved in the disease.
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
September 1989,
Proceedings of the National Academy of Sciences of the United States of America,
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
October 1996,
International journal of oncology,
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
May 1993,
Lancet (London, England),
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
February 2001,
British journal of cancer,
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
May 1995,
Journal of clinical pathology,
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
June 1992,
Lancet (London, England),
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
July 1997,
Genes, chromosomes & cancer,
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
July 1997,
Gynecologic oncology,
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
January 1992,
Lancet (London, England),
M L Loupart, and
S Adams, and
J A Armour, and
R Walker, and
W Brammar, and
J Varley
September 1995,
Journal of the National Cancer Institute,
